Security key
98956P102
ZIMMER BIOMET HOLDINGS, INC. - COMMON STOCK (ZBH)
CUSIP: 98956P102
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 195,068,439
- Total 13F shares
- 192,137,859
- Share change
- -6,487,196
- Total reported value
- $17,369,534,102
- Put/Call ratio
- 114%
- Price per share
- $90.42
- Number of holders
- 902
- Value change
- -$584,549,220
- Number of buys
- 386
- Number of sells
- 405
Report period
Q1 2026
Institutions
902
Top holders
10
ZBH full security history
Previous quarter: Q4 2025
ZIMMER BIOMET HOLDINGS, INC. SEC filings
ZIMMER BIOMET HOLDINGS, INC. company facts
ZIMMER BIOMET HOLDINGS, INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 98956P102
Recent filing periods:
Top shareholders of ZBH - ZIMMER BIOMET HOLDINGS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DODGE & COX |
13F
13D/G
|
Company |
11%
from 13D/G
|
23,506,849
|
$2,113,735,862 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.8%
|
15,573,187
|
$1,580,678,480 | $0 | 31 Mar 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
7.5%
|
14,767,527
|
$1,335,279,791 | $0 | 31 Mar 2026 | |
| HARRIS ASSOCIATES L P |
13D/G
13F
|
Company |
6.2%
|
12,264,703
|
$1,102,842,094 | $0 | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
|
Company · T. Rowe Price Associates, Inc. |
4.1%
from 13D/G
|
13,631,819
|
$1,225,774,000 | — | 31 Dec 2025 | |
| Ivan Tornos |
3/4/5
|
Chairman, President and CEO, Director |
0.04%
|
83,191
mixed-class rows
|
$8,994,821 | — | 06 Mar 2026 | |
| Suketu Upadhyay |
3/4/5
|
Exec VP, CFO |
0.04%
|
69,485
mixed-class rows
|
$7,085,256 | — | 06 Mar 2026 | |
| Chad F. Phipps |
3/4/5
|
Senior Vice President, Chief Legal, Corporate Affairs and Secretary |
0.03%
|
67,760
mixed-class rows
|
$6,668,973 | — | 06 Mar 2026 | |
| Sang Yi |
3/4/5
|
Group President, Asia Pacific |
0.02%
|
32,251
mixed-class rows
|
$3,314,229 | -$389,803 | 06 Mar 2026 | |
| Wilfred van Zuilen |
3/4/5
|
Group Pres, EMEA |
0.02%
|
30,991
mixed-class rows
|
$3,176,325 | — | 06 Mar 2026 | |
| Lori Winkler |
3/4/5
|
SVP and CHRO |
0.01%
|
10,224
mixed-class rows
|
$1,151,937 | -$560,809 | 12 Mar 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
23,483,741
|
$2,111,657,991 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
8,826,974
|
$795,814,407 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
3.7%
|
7,127,913
|
$640,941,937 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.4%
|
6,685,987
|
$601,203,951 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
5,233,834
|
$468,821,061 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.5%
|
4,915,237
|
$441,978,301 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2.1%
|
3,999,410
|
$359,626,948 | — | 31 Dec 2025 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
1.9%
|
3,613,425
|
$324,920,000 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
3,361,075
|
$302,227,865 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.6%
|
3,141,135
|
$282,453,400 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.3%
|
2,475,768
|
$223,528,862 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
2,460,348
|
$221,234,492 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
2,199,955
|
$197,834,445 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
2,039,652
|
$183,405,509 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.94%
|
1,838,096
|
$165,281,913 | — | 31 Dec 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.88%
|
1,724,601
|
$155,076,122 | — | 31 Dec 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.79%
|
1,544,646
|
$139,054,222 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.79%
|
1,534,016
|
$137,938,719 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.75%
|
1,456,945
|
$131,008,495 | — | 31 Dec 2025 | |
| EQUITY INVESTMENT CORP |
13F
|
Company |
0.68%
|
1,333,446
|
$119,903,474 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.67%
|
1,312,911
|
$118,056,957 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.67%
|
1,300,615
|
$116,951,307 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.64%
|
1,243,818
|
$111,844,136 | — | 31 Dec 2025 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.63%
|
1,237,109
|
$111,241,000 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.57%
|
1,116,325
|
$100,379,944 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.52%
|
1,018,419
|
$91,576,272 | — | 31 Dec 2025 | |
| SOUND SHORE MANAGEMENT INC /CT/ |
13F
|
Company |
0.44%
|
850,757
|
$76,500,069 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.42%
|
817,246
|
$73,486,761 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
793,359
|
$71,338,976 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.39%
|
769,702
|
$69,211,602 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.39%
|
766,074
|
$68,885,373 | — | 31 Dec 2025 | |
| CAUSEWAY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.37%
|
728,498
|
$65,506,589 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.37%
|
715,229
|
$64,313,410 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.36%
|
697,753
|
$62,741,950 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.35%
|
678,869
|
$61,043,900 | — | 31 Dec 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
0.33%
|
636,784
|
$57,259,617 | — | 31 Dec 2025 | |
| Magellan Asset Management Ltd |
13F
|
Company |
0.33%
|
636,734
|
$57,255,121 | — | 31 Dec 2025 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
0.31%
|
601,515
|
$54,088,000 | — | 31 Dec 2025 | |
| Boston Partners |
13F
|
Company |
0.3%
|
592,236
|
$53,241,828 | — | 31 Dec 2025 |
Institutional Holders of ZIMMER BIOMET HOLDINGS, INC. - COMMON STOCK (ZBH) as of Q1 2026
As of 31 Mar 2026,
ZIMMER BIOMET HOLDINGS, INC. - COMMON STOCK (ZBH) was held by
902 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
192,137,859 shares.
The largest 10 holders included
Dodge & Cox, BlackRock, Inc., HARRIS ASSOCIATES L P, VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
902
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
941
Q1 2026 holders
902
Holder diff
-39
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.